Logo image of CRWV

COREWEAVE INC-CL A (CRWV) Stock Fundamental Analysis

USA - NASDAQ:CRWV - US21873S1087 - Common Stock

75.6243 USD
+0.72 (+0.97%)
Last: 11/19/2025, 9:48:09 AM
Fundamental Rating

1

Taking everything into account, CRWV scores 1 out of 10 in our fundamental rating. CRWV was compared to 85 industry peers in the IT Services industry. CRWV may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CRWV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CRWV has reported negative net income.
CRWV Yearly Net Income VS EBIT VS OCF VS FCFCRWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

The Return On Assets of CRWV (-4.31%) is worse than 63.53% of its industry peers.
CRWV has a Return On Equity of -29.59%. This is in the lower half of the industry: CRWV underperforms 70.59% of its industry peers.
The Return On Invested Capital of CRWV (0.94%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.31%
ROE -29.59%
ROIC 0.94%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRWV Yearly ROA, ROE, ROICCRWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 200 300 400

1.3 Margins

CRWV has a Operating Margin (6.28%) which is comparable to the rest of the industry.
With an excellent Gross Margin value of 74.46%, CRWV belongs to the best of the industry, outperforming 92.94% of the companies in the same industry.
Industry RankSector Rank
OM 6.28%
PM (TTM) N/A
GM 74.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRWV Yearly Profit, Operating, Gross MarginsCRWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100 -200

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRWV is destroying value.
CRWV has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for CRWV is higher compared to a year ago.
CRWV Yearly Shares OutstandingCRWV Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 100M 200M 300M 400M
CRWV Yearly Total Debt VS Total AssetsCRWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.88, we must say that CRWV is in the distress zone and has some risk of bankruptcy.
CRWV has a Altman-Z score of 0.88. This is in the lower half of the industry: CRWV underperforms 69.41% of its industry peers.
A Debt/Equity ratio of 1.94 is on the high side and indicates that CRWV has dependencies on debt financing.
The Debt to Equity ratio of CRWV (1.94) is worse than 75.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Altman-Z 0.88
ROIC/WACC0.11
WACC8.37%
CRWV Yearly LT Debt VS Equity VS FCFCRWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2B -2B 4B -4B

2.3 Liquidity

A Current Ratio of 0.52 indicates that CRWV may have some problems paying its short term obligations.
CRWV's Current ratio of 0.52 is on the low side compared to the rest of the industry. CRWV is outperformed by 91.76% of its industry peers.
A Quick Ratio of 0.52 indicates that CRWV may have some problems paying its short term obligations.
CRWV has a worse Quick ratio (0.52) than 91.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
CRWV Yearly Current Assets VS Current LiabilitesCRWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B 4B

4

3. Growth

3.1 Past

CRWV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.81%.
Looking at the last year, CRWV shows a very strong growth in Revenue. The Revenue has grown by 736.64%.
EPS 1Y (TTM)-57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)736.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CRWV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.31% yearly.
The Revenue is expected to grow by 68.91% on average over the next years. This is a very strong growth
EPS Next Y18.82%
EPS Next 2Y35.46%
EPS Next 3Y45.55%
EPS Next 5Y40.31%
Revenue Next Year181.61%
Revenue Next 2Y155.06%
Revenue Next 3Y112.06%
Revenue Next 5Y68.91%

3.3 Evolution

CRWV Yearly Revenue VS EstimatesCRWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
CRWV Yearly EPS VS EstimatesCRWV Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 1 -1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

CRWV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CRWV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRWV Price Earnings VS Forward Price EarningsCRWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRWV.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 43.36
CRWV Per share dataCRWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as CRWV's earnings are expected to grow with 45.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.46%
EPS Next 3Y45.55%

0

5. Dividend

5.1 Amount

CRWV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COREWEAVE INC-CL A

NASDAQ:CRWV (11/19/2025, 9:48:09 AM)

75.6243

+0.72 (+0.97%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)N/A N/A
Inst Owners54.7%
Inst Owner Change15.26%
Ins Owners7%
Ins Owner Change-1.59%
Market Cap37.44B
Revenue(TTM)3.53B
Net Income(TTM)-1.13B
Analysts72.78
Price Target136.12 (80%)
Short Float %9.21%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-202.79%
Min EPS beat(2)-379.88%
Max EPS beat(2)-25.71%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.39%
Min Revenue beat(2)9.95%
Max Revenue beat(2)12.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.29%
PT rev (3m)39.39%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)-59.96%
EPS NY rev (1m)-2.25%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)4.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.62
P/FCF N/A
P/OCF N/A
P/B 9.8
P/tB 13.36
EV/EBITDA 43.36
EPS(TTM)-4.13
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.12
BVpS7.72
TBVpS5.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.31%
ROE -29.59%
ROCE 1.19%
ROIC 0.94%
ROICexc 1%
ROICexgc 1.06%
OM 6.28%
PM (TTM) N/A
GM 74.46%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Debt/EBITDA 6.85
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 0.88
F-ScoreN/A
WACC8.37%
ROIC/WACC0.11
Cap/Depr(3y)1492.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)732.41%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y18.82%
EPS Next 2Y35.46%
EPS Next 3Y45.55%
EPS Next 5Y40.31%
Revenue 1Y (TTM)736.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year181.61%
Revenue Next 2Y155.06%
Revenue Next 3Y112.06%
Revenue Next 5Y68.91%
EBIT growth 1Y2344.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year970.11%
EBIT Next 3Y241.95%
EBIT Next 5Y135.73%
FCF growth 1Y-436.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.01%
OCF growth 3YN/A
OCF growth 5YN/A

COREWEAVE INC-CL A / CRWV FAQ

Can you provide the ChartMill fundamental rating for COREWEAVE INC-CL A?

ChartMill assigns a fundamental rating of 1 / 10 to CRWV.


What is the valuation status for CRWV stock?

ChartMill assigns a valuation rating of 1 / 10 to COREWEAVE INC-CL A (CRWV). This can be considered as Overvalued.


Can you provide the profitability details for COREWEAVE INC-CL A?

COREWEAVE INC-CL A (CRWV) has a profitability rating of 1 / 10.